Esther De La Viuda

Alcala De Henares, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Prevalence of vasomotor symptoms and the associated risk factors: the "Mi Menopausia" app study.

Prevalence of vasomotor symptoms and the associated risk factors: the "Mi Menopausia" app study.

Journal: Maturitas

Published: February 04, 2026

Recommendations for the management of menopausal vasomotor symptoms in clinical practice

Recommendations for the management of menopausal vasomotor symptoms in clinical practice

Journal: Semergen

Published: June 09, 2025

Quality of life at peri- and postmenopause: analysis of the results from app "Mi Menopausia".

Quality of life at peri- and postmenopause: analysis of the results from app "Mi Menopausia".

Journal: Maturitas

Published: January 19, 2025

Anamnesis Checklist for Informed Oral Contraceptive Choices: A Spanish Perspective.

Anamnesis Checklist for Informed Oral Contraceptive Choices: A Spanish Perspective.

Journal: Women's health reports (New Rochelle, N.Y.)

Published: October 30, 2024

Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis.

Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis.

Journal: Menopause (New York, N.Y.)

Published: February 22, 2024

Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review.

Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review.

Journal: Journal of clinical medicine

Published: June 20, 2023

Population-based survey on menopausal symptoms and treatment use.

Population-based survey on menopausal symptoms and treatment use.

Journal: Climacteric : the journal of the International Menopause Society

Published: November 09, 2022

Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.

Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.

Journal: Maturitas

Published: March 16, 2022

Impact of the Lockdown Due to COVID-19 Pandemic in the Use of Combined Hormonal Oral Contraception in Spain - Results of a National Survey: Encovid.

Impact of the Lockdown Due to COVID-19 Pandemic in the Use of Combined Hormonal Oral Contraception in Spain - Results of a National Survey: Encovid.

Journal: Open access journal of contraception

Published: February 13, 2021

Response to "Should estrogen be used in the co-treatment of COVID-19 patients?"

Response to "Should estrogen be used in the co-treatment of COVID-19 patients?"

Journal: Maturitas

Published: June 14, 2020

The thromboembolic risk in covid-19 women under hormonal treatment group.

The thromboembolic risk in covid-19 women under hormonal treatment group.

Journal: Maturitas

Published: May 26, 2020

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia.

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia.

Journal: Maturitas

Published: April 16, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026